FDA 483 - Fidia Farmaceutici S.p.A. - November 10, 2016
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Fidia Farmaceutici S.p.A. in Abano Terme, Italy, a medical device manufacturer, revealed a significant repeat observation regarding inadequate statistical techniques. The firm failed to adequately establish procedures for identifying valid statistical techniques for process capability and product characteristics, specifically concerning the sampling of rubber stoppers and glass syringes. This indicates a serious lapse in quality control processes.
ID · 7fd07162-c31b-4d3a-b6bb-575d3abbefba